Theralase Technologies, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Photodynamic Compounds and Methods for Activating Them Using Ionizing Radiation And/Or Other Electromagnetic Radiation for Therapy And/Or Diagnostics (US 10,335,608) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Apr 24, 2027The maintenance fee for Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy (US 11,793,818) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents (US 11,813,330) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Apparatus and method for multiwavelength photodynamic therapy (US 10,525,279) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,737,565 | Metal-glycoprotein complexes and their use as chemotherapeutic compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 10,111,936 | Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,525,279 | Apparatus and method for multiwavelength photodynamic therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 10,335,608 | Photodynamic Compounds and Methods for Activating Them Using Ionizing Radiation And/Or Other Electromagnetic Radiation for Therapy And/Or Diagnostics In force · High confidence | In force | High confidence | |
| US 11,241,587 | Fiber Optic Light Delivery, Monitoring and Apparatus Therefor In force · High confidence | In force | High confidence | |
| US 11,793,818 | Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 11,464,798 | Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same In force · From the USPTO record | In force | From the USPTO record | |
| US 12,311,190 | Apparatus and method for irradiating inside an object In force · From the USPTO record | In force | From the USPTO record | |
| US 12,721,854 | Inactivation of Pathogens Using Metal-Based Coordination Complexes, and Methods and Compositions for Treating and Preventing Microbial And/Or Viral Infections In force · Medium confidence | In force | Medium confidence | |
| US 11,813,330 | Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 no status recorded